That changed last year when OptumRx, a subsidiary of UnitedHealth Group, decided it would no longer cover the inhaler Schidtknecht used for a decade. On January 10, 2024, Schmidtknecht, 22, went to ...
Unable to afford the new cost, he left the pharmacy without the medication ... The Schmidtknechts allege that pharmacy ...